Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Josh C. Pleasure, M.D. who wrote (65)	11/1/1996 8:36:00 PM
From: Sean Janzen	of 1501

Josh, Because I was concerned that 60 days had passed since the announcement of the option agreement with Supergen, I talked to Mr. King today. He assured me that a deal would be worked out before the end of November. Apparently a licensing agreement for the TB antigen is further off. Mr. King mentioned that there are interested parties but he could not release any information at this time. I'm disappointed that the Abbott deal fell apart. I cannot believe the Abbott deal fell apart because of confusion of ownership of the TB antigen. Obviously, a TB deal does not make or break IZP. A deal would have added stability to the price of the stock in the event of an unfavorable result in the Human Clinical Trials of Apanol. Though there is no guarantee of investment from any fund in the near future, Mr. King stated that a number of biotech funds are interested in IZP. No surprise! This is probably the best time to accumulate shares of IZP. Best of luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next